Please login to the form below

Not currently logged in
Email:
Password:

BMJ reopens Israeli boycott debate

The British Medical Journal  reopens the debate over an academic boycott of Israel in its latest edition

The British Medical Journal (BMJ) has reopened the debate over an academic boycott of Israel in its latest edition.

Several doctors in the UK and the US have proposed a boycott of the BMJ, which as the official journal of the British Medical Association (BMA).

The features section of the July 21 edition published two opposing views in an article entitled: ìHead to head: Should we consider a boycott of Israeli academic institutions?î

Tom Hickey, of the University of Brighton, who was among the initiators of the resolution adopted by the University and Colleges Union (UCU) to consider imposing a boycott of Israeli academic institutions, wrote in favour of a boycott. Michael Baum, professor emeritus of surgery at University College London, wrote against the boycott. The journal also put the question to a vote in an online poll.

The UCU resolution prompted condemnation from some local academics, Jewish groups in the US, Canada and Britain. The UK government responded by sending its minister for higher education to Israel for a series of meetings.

30th July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics